A) upper left (dataset GSE68310), tracking of IFI27 expression in a community cohort with seasonal influenza. B) upper right (dataset GSE161731), tracking of IFI27 expression in non-hospitalized patients with COVID-19. C) lower left (dataset GSE178967), change of IFI27 expression in COVID-19 patients 5 days after study enrollment. D) lower right (dataset GSE169687), long-term tracking of S100A12 expression in COVID-19 patients.</p
<p>The magnitude of the Influenza Factor varies from inoculation through resolution of disease, for ...
COVID-19 manifests a spectrum of respiratory symptoms, with the more severe often requiring hospital...
COVID-19 manifests a spectrum of respiratory symptoms, with the more severe often requiring hospital...
A) upper panel (dataset GSE161731), comparison of S100A12 and IFI27 expression in healthy controls a...
A) upper panel, comparison of S100A12 and IFI27 expression in healthy controls and COVID-19 patients...
A) upper panel (dataset GSE152641), comparison of S100A12 and IFI27 expression in healthy controls a...
A) upper panel (dataset GSE184401), comparison of S100A12 and IFI27 expression in COVID-19 patients ...
A) upper panel (dataset GSE172114), comparison of S100A12 and IFI27 expression in moderate and criti...
A) upper left (dataset Zenodo 6120249), correlation between IFI27 expression and time since symptom ...
For coronavirus disease 2019 (COVID-19), a pandemic disease characterized by strong immune dysregula...
Robust biomarkers that predict disease outcomes amongst COVID-19 patients are necessary for both pat...
A) upper panel (dataset GSE189990), comparison of S100A12 expression in COVID-19 patients with diffe...
PurposeRobust biomarkers that predict disease outcomes amongst COVID-19 patients are necessary for b...
<p><b>(A)</b> C57Bl/6N (WT; black) or <i>Ifi35</i><sup>-/-</sup> (red) mice were intranasally infect...
<p>Cells were infected using an MOI = 4, and at between 2 and 10 hpi the host cell mRNA levels compa...
<p>The magnitude of the Influenza Factor varies from inoculation through resolution of disease, for ...
COVID-19 manifests a spectrum of respiratory symptoms, with the more severe often requiring hospital...
COVID-19 manifests a spectrum of respiratory symptoms, with the more severe often requiring hospital...
A) upper panel (dataset GSE161731), comparison of S100A12 and IFI27 expression in healthy controls a...
A) upper panel, comparison of S100A12 and IFI27 expression in healthy controls and COVID-19 patients...
A) upper panel (dataset GSE152641), comparison of S100A12 and IFI27 expression in healthy controls a...
A) upper panel (dataset GSE184401), comparison of S100A12 and IFI27 expression in COVID-19 patients ...
A) upper panel (dataset GSE172114), comparison of S100A12 and IFI27 expression in moderate and criti...
A) upper left (dataset Zenodo 6120249), correlation between IFI27 expression and time since symptom ...
For coronavirus disease 2019 (COVID-19), a pandemic disease characterized by strong immune dysregula...
Robust biomarkers that predict disease outcomes amongst COVID-19 patients are necessary for both pat...
A) upper panel (dataset GSE189990), comparison of S100A12 expression in COVID-19 patients with diffe...
PurposeRobust biomarkers that predict disease outcomes amongst COVID-19 patients are necessary for b...
<p><b>(A)</b> C57Bl/6N (WT; black) or <i>Ifi35</i><sup>-/-</sup> (red) mice were intranasally infect...
<p>Cells were infected using an MOI = 4, and at between 2 and 10 hpi the host cell mRNA levels compa...
<p>The magnitude of the Influenza Factor varies from inoculation through resolution of disease, for ...
COVID-19 manifests a spectrum of respiratory symptoms, with the more severe often requiring hospital...
COVID-19 manifests a spectrum of respiratory symptoms, with the more severe often requiring hospital...